Trials / Recruiting
RecruitingNCT04682483
Cardiogenic Shock Working Group Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Detailed description
The Cardiogenic Shock Working Group is an Academic Research Consortium involving multiple medical centers within the United States and includes a multicenter registry for patients with cardiogenic shock. De-identified clinical variables are collected from medical records and follow-up phone calls. There is currently no central database for cardiogenic shock, therefore analysis of cardiogenic shock on a larger scale is limited. A goal of the Cardiogenic Shock Working Group is to create a centralized registry, compiled of data from multiple institutions, to analyze clinical outcomes. The Cardiogenic Shock Working Group Registry will include a retrospective arm, where data is collected during the course of the hospital stay, and a prospective arm, where long-term outcomes will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vasopressor | The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin. |
| DRUG | Inotrope | Inotropes include dobutamine and milrinone. |
| DEVICE | Acute Mechanical Circulatory Support Devices | Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo. |
Timeline
- Start date
- 2017-12-04
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
- First posted
- 2020-12-23
- Last updated
- 2025-06-06
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04682483. Inclusion in this directory is not an endorsement.